-
March 1: The Week in Cancer News
Many women must make decisions about preserving fertility while dealing with a cancer diagnosis, and head and neck cancer survivors face a higher stroke risk.
by Kevin McLaughlin
-
February 23: The Week in Cancer News
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.
by Thomas Celona
-
February 16: The Week in Cancer News
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
by Kevin McLaughlin
-
February 9: The Week in Cancer News
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.
by Marci A. Landsmann
-
February 2: The Week in Cancer News
Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.
by Eric Fitzsimmons
-
January 26: The Week in Cancer News
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.
by Thomas Celona
-
January 19: The Week in Cancer News
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
by Eric Fitzsimmons
-
January 12: The Week in Cancer News
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
by Kevin McLaughlin
-
January 5: The Week in Cancer News
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
by Marci A. Landsmann
-
December 15: The Week in Cancer News
Study finds breast cancer survivors can opt for less frequent screening, and people with physical disabilities often encounter discrimination in cancer care.
by Thomas Celona
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore